PMID- 19168902 OWN - NLM STAT- MEDLINE DCOM- 20090611 LR - 20231213 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 50 IP - 6 DP - 2009 Jun TI - The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity. PG - 2903-12 LID - 10.1167/iovs.08-2957 [doi] AB - PURPOSE: The authors recently reported that a recombinant HSV-1 expressing two extra copies of glycoprotein K (gK) exacerbated corneal scarring (CS) in mice. The authors also identified a peptide, STVVLITAYGLVLVW, within the signal sequence of gK as an immunodominant gK T-cell-stimulatory region both in vitro and in vivo and identified a highly conserved potential CD8(+) T-cell epitope (ITAYGLVL) within the peptide. In this study, the effect of giving this octamer (8mer) as an eye drop 1 hour before ocular infection with HSV-1 was investigated. METHODS: Naive mice and rabbits received the gK 8mer or control peptides as eye drops and were then ocularly infected with HSV-1. Virus replication in the eye and trigeminal ganglia (TG), survival, CS, and relative amounts of gB, gK, CD4, CD8, IFN-gamma, and granzyme A/B transcripts were determined in the cornea and TG of infected animals at various times after infection. The effect of the gK 8mer was also analyzed in immunized HLA transgenic mice. RESULTS: The gK 8mer resulted in a short-term significant increase in virus replication in the eyes of BALB/c mice, C57BL/6 mice, and NZW rabbits. gK 8mer treatment also increased viral neurovirulence and viral induced CS in ocularly infected mice. Moreover, in HSV-infected humanized HLA-A*0201 transgenic mice, the gK 8mer epitope induced strong IFN-gamma-producing cytotoxic CD8(+) T-cell responses, as assessed by CD107a/b expression and IFN-gamma ELISAs. CONCLUSIONS: gK 8mer induced CD8(+) T-cell responses were unlikely to occur soon enough to account for increased virus replication on day 1 after infection. In contrast, the data are consistent with CD8(+) T cells being involved in the appearance of CS at late times after infection. In addition, the gK peptide may affect viral replication and innate immune responses through other undefined mechanisms. FAU - Mott, Kevin R AU - Mott KR AD - Center for Neurobiology and Vaccine Development, Ophthalmology Research, Cedars-Sinai Medical Center Burns and Allen Research Institute, Los Angeles, California 90048, USA. FAU - Chentoufi, Aziz A AU - Chentoufi AA FAU - Carpenter, Dale AU - Carpenter D FAU - BenMohamed, Lbachir AU - BenMohamed L FAU - Wechsler, Steven L AU - Wechsler SL FAU - Ghiasi, Homayon AU - Ghiasi H LA - eng GR - EY13615/EY/NEI NIH HHS/United States GR - R01 EY019896/EY/NEI NIH HHS/United States GR - R03 EY014017/EY/NEI NIH HHS/United States GR - R01 EY014900/EY/NEI NIH HHS/United States GR - R01 EY024618/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20090124 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (Lamp1 protein, mouse) RN - 0 (Lysosomal Membrane Proteins) RN - 0 (Ophthalmic Solutions) RN - 0 (Peptide Fragments) RN - 0 (UL53 protein, Human herpesvirus 1) RN - 0 (Viral Proteins) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - CD8-Positive T-Lymphocytes/*immunology MH - Cornea/virology MH - Cytotoxicity, Immunologic MH - Disease Models, Animal MH - Enzyme-Linked Immunosorbent Assay MH - Epitopes, T-Lymphocyte/*immunology MH - Female MH - Herpesvirus 1, Human/*pathogenicity/*physiology MH - Immunization MH - Interferon-gamma MH - Keratitis, Herpetic/immunology/*virology MH - Lysosomal Membrane Proteins MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Ophthalmic Solutions MH - Peptide Fragments/administration & dosage MH - Rabbits MH - Reverse Transcriptase Polymerase Chain Reaction MH - Viral Proteins/*immunology MH - Virus Replication/*physiology EDAT- 2009/01/27 09:00 MHDA- 2009/06/12 09:00 CRDT- 2009/01/27 09:00 PHST- 2009/01/27 09:00 [entrez] PHST- 2009/01/27 09:00 [pubmed] PHST- 2009/06/12 09:00 [medline] AID - iovs.08-2957 [pii] AID - 10.1167/iovs.08-2957 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2903-12. doi: 10.1167/iovs.08-2957. Epub 2009 Jan 24.